Trial Profile
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy of Neovacs' TNF-Kinoid in Adult Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tumour necrosis factor-alpha kinoid (Primary) ; Montanide ISA-51
- Indications Rheumatoid arthritis
- Focus Biomarker; Therapeutic Use
- Sponsors Neovacs
- 04 Mar 2015 Results published in a Neovacs media release.
- 27 Feb 2015 Primary endpoint (Change in DAS28-CRP between Month 6 and baseline) has not been met.
- 20 Jan 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.